M. Vandana

Nanomedicine: Emerging Field of Nanotechnology to Human Health

C. Mohanty, M. Vandana, Abhalaxmi Singh, 2012 .

Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.

M. Vandana, S. Sahoo, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.

M. Vandana, S. Sahoo, 2009, Nanomedicine.

Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer.

M. Vandana, S. Sahoo, 2010, Biomaterials.

Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.

M. Vandana, Geeta Arya, S. Sahoo, 2011, Nanomedicine : nanotechnology, biology, and medicine.

Cytoprotective activity of Amla (Emblica officinalis) against chromium (VI) induced oxidative injury in murine macrophages

M. Vandana, W. Selvamurthy, G. Ilavazhagan, 2003, Phytotherapy research : PTR.

Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts

M. Hidalgo, C. Heeschen, S. Hahn, 2013, PloS one.

Reduced folate carrier independent internalization of PEGylated pemetrexed: a potential nanomedicinal approach for breast cancer therapy.

M. Vandana, S. Sahoo, 2012, Molecular pharmaceutics.

Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer.

M. Vandana, S. Sahoo, 2010, Biomaterials.